AEON Biopharma Inc (AEON)
1.39
+0.03
(+2.21%)
USD |
NYAM |
Jun 14, 16:00
1.34
-0.05
(-3.60%)
After-Hours: 20:00
AEON Biopharma Research and Development Expense (Annual): 34.75M for Dec. 31, 2022
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2022 | 34.75M |
| December 31, 2021 | 25.73M |
| Date | Value |
|---|---|
| December 31, 2020 | 7.319M |
| December 31, 2019 | 4.814M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
4.814M
Minimum
2019
34.75M
Maximum
2022
18.15M
Average
16.52M
Median
Research and Development Expense (Annual) Benchmarks
| Amgen Inc | 4.784B |
| Gilead Sciences Inc | 5.718B |
| Pulse Biosciences Inc | 27.80M |
| Amneal Pharmaceuticals Inc | 167.78M |
| Xilio Therapeutics Inc | 52.14M |